Cytocast can simulate drugs acting on surface protein receptors Cytocast can simulate drugs acting on surface protein receptors ADVstudio2021-02-25T19:24:25+00:00 Social Network FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail Related Posts Cytocast gains regulatory approval for informing treatment decisions in patients with Fibrosis Cytocast can simulate the transcriptional modification caused by drug administration. Drug development companies can use Cytocast Whole Cell Simulator to accelerate drug development. Covid-19 didn’t stop us! We fight to stop COVID: we use Cytocast to find treatments against lung fibrosis, which causes some of the complications for patients. A demo of Cytocast Whole Cell Simulator© is released 2020: Cytocast wins the ”Promising future for a Medical Professional ” award at the Health Ventures Lab of GE Healthcare Cytocast is incorporated in Budapest Cytocast correctly predict the effects of Metformin treatment Cytocast proof of concept is published in Plos Computational Biology
